spacer
spacer

PDBsum entry 1nqc

Go to PDB code: 
protein ligands links
Hydrolase PDB id
1nqc

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
217 a.a. *
Ligands
C4P
Waters ×245
* Residue conservation analysis
PDB id:
1nqc
Name: Hydrolase
Title: Crystal structures of cathepsin s inhibitor complexes
Structure: Cathepsin s. Chain: a. Ec: 3.4.22.27
Source: Homo sapiens. Human. Organism_taxid: 9606
Resolution:
1.80Å     R-factor:   0.199     R-free:   0.219
Authors: T.A.Pauly,T.Sulea,M.Ammirati,J.Sivaraman,D.E.Danley,M.C.Griffor, A.V.Kamath,I.K.Wang,E.R.Laird,R.Menard,M.Cygler,V.L.Rath
Key ref:
T.A.Pauly et al. (2003). Specificity determinants of human cathepsin s revealed by crystal structures of complexes. Biochemistry, 42, 3203-3213. PubMed id: 12641451 DOI: 10.1021/bi027308i
Date:
21-Jan-03     Release date:   15-Apr-03    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P25774  (CATS_HUMAN) -  Cathepsin S from Homo sapiens
Seq:
Struc:
331 a.a.
217 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class: E.C.3.4.22.27  - cathepsin S.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Similar to cathepsin L, but with much less activity on Z-Phe-Arg-|-NHMec, and more activity on the Z-Val-Val-Arg-|-Xaa compound.

 

 
DOI no: 10.1021/bi027308i Biochemistry 42:3203-3213 (2003)
PubMed id: 12641451  
 
 
Specificity determinants of human cathepsin s revealed by crystal structures of complexes.
T.A.Pauly, T.Sulea, M.Ammirati, J.Sivaraman, D.E.Danley, M.C.Griffor, A.V.Kamath, I.K.Wang, E.R.Laird, A.P.Seddon, R.Ménard, M.Cygler, V.L.Rath.
 
  ABSTRACT  
 
Cathepsin S, a lysosomal cysteine protease of the papain superfamily, has been implicated in the preparation of MHC class II alphabeta-heterodimers for antigen presentation to CD4+ T lymphocytes and is considered a potential target for autoimmune-disease therapy. Selective inhibition of this enzyme may be therapeutically useful for attenuating the hyperimmune responses in a number of disorders. We determined the three-dimensional crystal structures of human cathepsin S in complex with potent covalent inhibitors, the aldehyde inhibitor 4-morpholinecarbonyl-Phe-(S-benzyl)Cys-Psi(CH=O), and the vinyl sulfone irreversible inhibitor 4-morpholinecarbonyl-Leu-Hph-Psi(CH=CH-SO(2)-phenyl) at resolutions of 1.8 and 2.0 A, respectively. In the structure of the cathepsin S-aldehyde complex, the tetrahedral thiohemiacetal adduct favors the S-configuration, in which the oxygen atom interacts with the imidazole group of the active site His164 rather than with the oxyanion hole. The present structures provide a detailed map of noncovalent intermolecular interactions established in the substrate-binding subsites S3 to S1' of cathepsin S. In the S2 pocket, which is the binding affinity hot spot of cathepsin S, the Phe211 side chain can assume two stable conformations that accommodate either the P2-Leu or a bulkier P2-Phe side chain. This structural plasticity of the S2 pocket in cathepsin S explains the selective inhibition of cathepsin S over cathepsin K afforded by inhibitors with the P2-Phe side chain. Comparison with the structures of cathepsins K, V, and L allows delineation of local intermolecular contacts that are unique to cathepsin S.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
21342054 A.Lee-Dutra, D.K.Wiener, and S.Sun (2011).
Cathepsin S inhibitors: 2004-2010.
  Expert Opin Ther Pat, 21, 311-337.  
20652927 L.Mendieta, A.Picó, T.Tarragó, M.Teixidó, M.Castillo, L.Rafecas, A.Moyano, and E.Giralt (2010).
Novel peptidyl aryl vinyl sulfones as highly potent and selective inhibitors of cathepsins L and B.
  ChemMedChem, 5, 1556-1567.  
19663682 R.L.Cunha, I.E.Gouvêa, G.P.Feitosa, M.F.Alves, D.Brömme, J.V.Comasseto, I.L.Tersariol, and L.Juliano (2009).
Irreversible inhibition of human cathepsins B, L, S and K by hypervalent tellurium compounds.
  Biol Chem, 390, 1205-1212.  
18793409 S.J.Melton, and S.J.Landry (2008).
Three dimensional structure directs T-cell epitope dominance associated with allergy.
  Clin Mol Allergy, 6, 9.  
16699182 D.E.Danley (2006).
Crystallization to obtain protein-ligand complexes for structure-aided drug design.
  Acta Crystallogr D Biol Crystallogr, 62, 569-575.  
17075137 G.Kaulmann, G.J.Palm, K.Schilling, R.Hilgenfeld, and B.Wiederanders (2006).
The crystal structure of a Cys25 -> Ala mutant of human procathepsin S elucidates enzyme-prosequence interactions.
  Protein Sci, 15, 2619-2629.
PDB code: 2c0y
16972799 M.Linke, R.E.Gordon, M.Brillard, F.Lecaille, G.Lalmanach, and D.Brömme (2006).
Degradation of apolipoprotein B-100 by lysosomal cysteine cathepsins.
  Biol Chem, 387, 1295-1303.  
17081125 T.Rückrich, J.Brandenburg, A.Cansier, M.Müller, S.Stevanović, K.Schilling, B.Wiederanders, A.Beck, A.Melms, M.Reich, C.Driessen, and H.Kalbacher (2006).
Specificity of human cathepsin S determined by processing of peptide substrates and MHC class II-associated invariant chain.
  Biol Chem, 387, 1503-1511.  
16307485 L.Puzer, S.S.Cotrin, M.H.Cezari, I.Y.Hirata, M.A.Juliano, I.Stefe, D.Turk, B.Turk, L.Juliano, and A.K.Carmona (2005).
Recombinant human cathepsin X is a carboxymonopeptidase only: a comparison with cathepsins B and L.
  Biol Chem, 386, 1191-1195.  
12824164 K.M.Connolly, B.T.Smith, R.Pilpa, U.Ilangovan, M.E.Jung, and R.T.Clubb (2003).
Sortase from Staphylococcus aureus does not contain a thiolate-imidazolium ion pair in its active site.
  J Biol Chem, 278, 34061-34065.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer